<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04235023</url>
  </required_header>
  <id_info>
    <org_study_id>49RC19-0226</org_study_id>
    <nct_id>NCT04235023</nct_id>
  </id_info>
  <brief_title>PTP1B Implication in the Vascular Dysfunction Associated With Obstructive Sleep Apnea</brief_title>
  <acronym>MacroSAS</acronym>
  <official_title>PTP1B Implication in the Vascular Dysfunction Associated With Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive sleep apnea (OSA) syndrome is associated with increased vascular dysfunction and
      atherosclerosis. Especially, it has been shown that OSA associated intermittent hypoxia
      represents a pro inflammatory stimulus resulting in macrophage polarization.

      Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin signaling pathways
      involved in atherosclerosis. It has been shown that myeloid PTP1B deficiency protects against
      atherosclerosis.

      As hypoxia has also been shown to increase PTP1B expression and activity, this study will
      evaluate the myeloid PTP1B expression and activity in patients with OSA as compared to
      controls and will investigate myeloid PTP1B involvement in the vascular pro inflammatory
      precess described in OSA.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2020</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>patients with OSA 'apnea hypopnea index ≥ 15 per hour) as compared to controls (an apnea hypopnea index &lt; 15 per hour)</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>myeloid PTP1B expression</measure>
    <time_frame>baseline</time_frame>
    <description>Peripheral blood will be collected from OSA and non OSA patients. Macrophage will be isolated by specific centrifugation. PTP1B expression will be assessed by Western Blot.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>myeloid PTP1B activity</measure>
    <time_frame>baseline</time_frame>
    <description>Peripheral blood will be collected from OSA and non OSA patients. Macrophage will be isolated by specific centrifugation. PTP1B activity will be assessed by specific colorimetric assay.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PTP1B exosomal expression.</measure>
    <time_frame>baseline</time_frame>
    <description>Peripheral blood will be collected from OSA and non OSA patients. Exosomes will be isolated by consecutive centrifugations. PTP1B expression will be assessed by Western Blot.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>in vitro PTP1B implication on macrophage inflammatory response</measure>
    <time_frame>baseline</time_frame>
    <description>Macrophage isolated from patients will be stimulated by pro inflammatory agents (IL6, TNF alpha) in the presence and absence of PTP1B inhibitor (MSI-1436). The inflammatory response will be assessed by measuring inflammatory cytokines in the supernatant by ELISA.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sleep Apnea</condition>
  <condition>Inflammation</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>OSA patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 patients investigated for suspected OSA with an apnea hypopnea index ≥ 15 per hour</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non OSA patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 patients investigated for suspected OSA with an apnea hypopnea index &lt; 15 per hour</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>myeloid PTP1B expression analysis</intervention_name>
    <description>peripheral blood macrophage PTP1B expression</description>
    <arm_group_label>OSA patients</arm_group_label>
    <arm_group_label>non OSA patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overnight polysomnographic recording for suspected OSA

          -  Apnea hypopnea index ≥ 15 per hour for OSA patients

          -  Apnea hypopnea index &lt; 15 per hour for non OSA patients

        Exclusion Criteria:

          -  past history of cardiovascular diseases

          -  diabetes

          -  dyslipidemia

          -  hypertension

          -  obesity (body mass index &gt; 35 kg/m2

          -  past history or ongoing inflammatory diseases

          -  cognition impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wojciech Trzepizur, MD Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Angers University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wojciech Trzepizur, MD PhD</last_name>
    <phone>+33680575272</phone>
    <email>wotrzepizur@chu-angers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Wojciech Trzepizur, MD Ph D</last_name>
      <phone>+33680575272</phone>
      <email>wotrzepizur@chu-angers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 7, 2020</study_first_submitted>
  <study_first_submitted_qc>January 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 21, 2020</study_first_posted>
  <last_update_submitted>January 17, 2020</last_update_submitted>
  <last_update_submitted_qc>January 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PTP1B</keyword>
  <keyword>macrophage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

